RxDoctor Payments Data

Cassandra King

Adult Health · Moline, ILNPI 1831466077

Payments from drug & device makers

$791in general payments, 2019–2025

Across 21 payments — averaging $37.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$218
  • Boehringer Ingelheim$140
  • Cvrx, Inc.$128
  • E.r. Squibb & Sons, L.L.C.$79
  • Novo Nordisk$53
  • Astellas Pharma US Inc$45
  • plus $129 from 5 others

What the payments were for

  • Food & beverage$74694%
  • Education$456%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$791 in reported general payments places this provider in the 65th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Medicare billing

Part B allowed, 2024
$62,200
Medicare patients
427
Services billed
939

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$106,778
EntrestoSacubitril/Valsartan33$29,100
BrilintaTicagrelor36$26,001
XareltoRivaroxaban17$16,463
Nitroglycerin PatchNitroglycerin83$5,641
Metoprolol Succinate242$3,553
ClopidogrelClopidogrel Bisulfate132$1,561
Isosorbide Mononitrate ErIsosorbide Mononitrate78$1,152
Amlodipine Besylate132$903
Diltiazem 24hr Er (Cd)Diltiazem Hcl19$854
Lisinopril119$835
Potassium Chloride73$765
Rosuvastatin Calcium78$681
Metoprolol Tartrate96$622
Carvedilol82$533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$106,77897 claims
NovartisEntresto$41$29,10033 claims
Johnson & JohnsonXarelto$17$16,46317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 553 adult health providers in Illinois.

Other adult health in Moline

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →